May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

May 01, 2025

Health Care Shortage: Who’s Left Out?

“The ER then says, ‘OK, you should follow up with your primary care provider,’ and they’re like, ‘We don’t have one.’”

KFF Health News

May 01, 2025

Psilocybin Shows Promise for Parkinson's Disease

First clinical trial demonstrates psilocybin therapy significantly improves depression, anxiety, and motor symptoms.

Conexiant

April 30, 2025

FDA Approves FcRn Blocker for Broad gMG Use

The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.

Conexiant

April 30, 2025

Is That IPA PFAS-Free?

“Approximately 18% of U.S. breweries are located within zip codes with detectable Per- and polyfluoroalkyl substances (PFAS) in drinking water."

Conexiant

April 29, 2025

Foley Catheter Management: New Best Practices, Pitfalls

Foley catheter use is associated with a wide range of complications, from infections to urethral erosion.

Conexiant

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant